PORTSMOUTH, N.H. and KALAMAZOO, Mich., May 07, 2026 (GLOBE NEWSWIRE)-- MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies ...
Epredia has received 510(k) clearance from the US Food and Drug Administration (FDA) for the E1000 Dx, a digital pathology workflow solution for streamlining laboratory cancer diagnostics. Available ...
PORTSMOUTH, N.H. & KALAMAZOO, Mich.--(BUSINESS WIRE)--Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results